HK Stock MarketDetailed Quotes
08037 CH BIOTECH SER
- 0.440
- +0.080+22.22%
Market Closed Nov 22 16:08 CST
429.32MMarket Cap-2972P/E (TTM)
0.440High0.330Low150.00KVolume0.340Open0.360Pre Close53.65KTurnover0.02%Turnover RatioLossP/E (Static)975.73MShares0.80052wk High1.10P/B429.32MFloat Cap0.25052wk Low--Dividend TTM975.73MShs Float3.985Historical High--Dividend LFY30.56%Amplitude0.114Historical Low0.357Avg Price5000Lot Size--Div YieldTTM--Div Yield LFY
CH BIOTECH SER Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -82.21%32.45M | -88.55%211.99M | -84.27%200.71M | -73.45%182.36M | -66.01%130.56M | 196.83%1.85B | 152.42%1.28B | 83.59%686.91M | 149.13%384.09M | -4.88%623.76M |
| Operating income | -82.21%32.45M | -88.55%211.99M | -84.27%200.71M | -73.45%182.36M | -66.01%130.56M | 196.83%1.85B | 152.42%1.28B | 83.59%686.91M | 149.13%384.09M | -4.88%623.76M |
| Cost of sales | 70.62%-35.56M | 76.33%-177.66M | 72.05%-150.79M | 63.55%-121.03M | 58.12%-81.4M | -182.45%-750.58M | -154.70%-539.44M | -110.66%-332.01M | -146.18%-194.36M | 16.09%-265.74M |
| Operating expenses | 70.62%-35.56M | 76.33%-177.66M | 72.05%-150.79M | 63.55%-121.03M | 58.12%-81.4M | -182.45%-750.58M | -154.70%-539.44M | -110.66%-332.01M | -146.18%-194.36M | 16.09%-265.74M |
| Gross profit | -105.07%-3.11M | -96.88%34.32M | -93.22%49.92M | -82.72%61.33M | -74.09%49.16M | 207.51%1.1B | 150.78%736.31M | 63.88%354.9M | 152.24%189.73M | 5.59%358.02M |
| Selling expenses | 10.01%-6.55M | -6.44%-14.61M | -4.09%-10.61M | 32.06%-7.28M | 4.74%-3.72M | -17.08%-13.73M | -11.87%-10.19M | -74.63%-10.71M | -24.44%-3.91M | 1.05%-11.72M |
| Administrative expenses | -13.77%-88.47M | 42.63%-138.34M | 30.99%-108.73M | 17.12%-77.77M | 17.71%-44.72M | -53.52%-241.16M | -49.38%-157.56M | -47.69%-93.83M | -62.60%-54.34M | -18.56%-157.08M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | 453.58%2.71M | --2.71M | --2.71M | --1.97M | 1,140.43%489K |
| -Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | ---- | 453.58%2.71M | --2.71M | --2.71M | --1.97M | 1,140.43%489K |
| Impairment and provision | ---- | -195.04%-5.06M | ---- | ---- | ---- | -582.87%-1.71M | --859K | ---- | ---- | 78.08%-251K |
| -Other impairment is provision | ---- | -195.04%-5.06M | ---- | ---- | ---- | -582.87%-1.71M | --859K | ---- | ---- | 78.08%-251K |
| Special items of operating profit | -155.63%-26.46M | -185.99%-3.99M | -1,403.46%-13.89M | -367.33%-10.35M | -807.50%-1.82M | 1,961.78%4.64M | -311.44%-924K | 897.94%3.87M | -199.01%-200K | -96.13%225K |
| Operating profit | -265.71%-124.59M | -114.99%-127.67M | -114.58%-83.31M | -113.26%-34.07M | -100.82%-1.09M | 349.03%851.71M | 218.29%571.21M | 74.46%256.95M | 242.88%133.26M | -4.86%189.68M |
| Financing cost | -75.70%-4.69M | -51.96%-5.31M | -20.77%-3.94M | -15.45%-2.67M | -11.18%-1.35M | 46.58%-3.5M | 38.35%-3.26M | 43.33%-2.31M | 46.62%-1.22M | -0.69%-6.54M |
| Share of profit from joint venture company | ---- | -83.68%-7.68M | -211.87%-7.67M | -168.51%-2.77M | ---1.49M | ---4.18M | ---2.46M | ---1.03M | ---- | ---- |
| Special items of earning before tax | -79.66%3.02M | -107.25%-1.36M | 207.44%14.83M | 9,655.26%14.83M | ---26K | 861.82%18.79M | 207.06%4.82M | 103.37%152K | ---- | -124.84%-2.47M |
| Earning before tax | -411.64%-126.26M | -116.46%-142.03M | -114.04%-80.09M | -109.72%-24.68M | -103.00%-3.96M | 377.58%862.83M | 236.12%570.31M | 82.95%253.76M | 260.92%132.04M | -10.91%180.67M |
| Tax | 117.31%527K | 100.84%1.32M | 97.55%-2.61M | 93.58%-3.04M | 84.99%-3.82M | -226.97%-157.26M | -182.43%-106.7M | -59.51%-47.4M | -172.41%-25.46M | -36.72%-48.1M |
| After-tax profit from continuing operations | -353.56%-125.73M | -119.94%-140.71M | -117.84%-82.7M | -113.43%-27.72M | -107.30%-7.78M | 432.21%705.57M | 251.51%463.61M | 89.34%206.36M | 291.30%106.59M | -20.91%132.57M |
| Earning after tax | -353.56%-125.73M | -119.94%-140.71M | -117.84%-82.7M | -113.43%-27.72M | -107.30%-7.78M | 432.21%705.57M | 251.51%463.61M | 89.34%206.36M | 291.30%106.59M | -20.91%132.57M |
| Minority profit | -1,758.13%-45.81M | -110.11%-45.26M | -105.50%-16.72M | -98.00%2.76M | -89.40%7.59M | 295.35%447.48M | 190.61%304.09M | 63.00%138.14M | 181.85%71.65M | -17.65%113.19M |
| Profit attributable to shareholders | -162.16%-79.92M | -136.98%-95.45M | -141.36%-65.98M | -144.68%-30.48M | -144.01%-15.38M | 1,231.37%258.09M | 485.29%159.52M | 181.45%68.22M | 1,820.73%34.94M | -35.75%19.39M |
| Basic earnings per share | -159.38%-0.083 | -136.94%-0.099 | -140.96%-0.068 | -145.07%-0.032 | -144.44%-0.016 | 1,240.00%0.268 | 492.86%0.166 | 184.00%0.071 | 1,700.00%0.036 | -35.48%0.02 |
| Diluted earnings per share | -159.38%-0.083 | -136.94%-0.099 | -140.96%-0.068 | -145.07%-0.032 | -144.44%-0.016 | 1,240.00%0.268 | 492.86%0.166 | 184.00%0.071 | 1,700.00%0.036 | -35.48%0.02 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Rosenmei Certified Public Accountants | -- | -- | -- | Rosenmei Certified Public Accountants | -- | -- | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data